Nonprofit research organization Biohub, backed by Mark Zuckerberg and Priscilla Chan, is leading a $1.8 billion initiative to develop AI models capable of predicting cell behavior. The program integrates compute, laboratory equipment, and standardized biological datasets to accelerate drug discovery and biological research.

Funding for the initiative includes $300 million combined from Meta, Google DeepMind, and Isomorphic Labs, over $500 million from the US Department of Energy for lab testing and compute, and $500 million in prior federal NIH grants. Biohub is contributing to standardization efforts following an earlier $500 million commitment to its Virtual Biology Initiative.

Commercial contributors will receive one year of exclusive access to datasets funded by their investments before they are released publicly, while government-funded data will be public immediately. The initial standardized dataset is scheduled for release in approximately one year.

Why it matters

  • Accelerates AI drug discovery through large-scale standardization of public and private biological datasets.

  • Signals massive cross-sector capital deployment into predictive cell biology by major tech firms and government agencies.

Source: the-decoder.com